Last reviewed · How we verify
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Phase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus.
Details
| Lead sponsor | Biomea Fusion Inc. |
|---|---|
| Phase | PHASE2 |
| Status | TERMINATED |
| Enrolment | 37 |
| Start date | Thu Dec 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Jul 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Type 1 Diabetes Mellitus
Interventions
- BMF-219
Countries
Canada, United States